| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JACC.2004.11.006 |
| P8608 | Fatcat ID | release_mbcxmtktz5eftnjanjx47jitry |
| P698 | PubMed publication ID | 15680730 |
| P5875 | ResearchGate publication ID | 8050881 |
| P50 | author | Thomas Lüscher | Q62560161 |
| Frank Ruschitzka | Q63107473 | ||
| P2093 | author name string | Beat A Michel | |
| Michel Neidhart | |||
| Renate E Gay | |||
| Steffen Gay | |||
| Frank Enseleit | |||
| Roberto Corti | |||
| Georg Noll | |||
| Rémy Chenevard | |||
| Jens P Hellermann | |||
| Walter Riesen | |||
| David Hürlimann | |||
| Matthias Hermann | |||
| Lukas E Spieker | |||
| Frank Hermann | |||
| Adrian Forster | |||
| Diana Frey | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| simvastatin | Q670131 | ||
| P304 | page(s) | 461-464 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Simvastatin improves endothelial function in patients with rheumatoid arthritis | |
| P478 | volume | 45 |
| Q37378103 | Antiphospholipid antibodies in rheumatoid arthritis: identifying the dominoes |
| Q37464427 | Breaking old paradigms: Th17 cells in autoimmune arthritis |
| Q33943374 | Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment |
| Q36283434 | Cardiovascular involvement in rheumatoid arthritis |
| Q47859328 | Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project |
| Q34530587 | Effect of high-intensity statin treatment in rheumatoid arthritis: a case with possible coronary atheroma regression and progression of rheumatoid valve degeneration |
| Q46394312 | Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis |
| Q44973053 | Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial |
| Q34072179 | Endothelial dysfunction in chronic inflammatory diseases |
| Q37646768 | Ezetimibe/simvastatin |
| Q51652663 | Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial |
| Q24812354 | Local hyperemia to heating is impaired in secondary Raynaud's phenomenon |
| Q37058791 | Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion |
| Q92619532 | Oxidative Stress in Rheumatoid Arthritis: What the Future Might Hold regarding Novel Biomarkers and Add-On Therapies |
| Q33691624 | Persistence with Statins and Onset of Rheumatoid Arthritis: A Population-Based Cohort Study |
| Q37549027 | Premature vascular damage in systemic lupus erythematosus: an imbalance of damage and repair? |
| Q35994802 | Preventing Heart Failure in Inflammatory and Immune Disorders |
| Q35869041 | Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis |
| Q38149252 | Rheumatoid arthritis and cardiovascular disease |
| Q36574986 | Rheumatoid arthritis and the heart |
| Q30667212 | Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: results from the RORA-AS statin intervention study |
| Q38864670 | Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection |
| Q37027316 | Statin treatment for rheumatoid arthritis: a promising novel indication |
| Q33588462 | Statin use and mortality in rheumatoid arthritis: a general population-based cohort study |
| Q36695979 | Statins and the vascular endothelial inflammatory response |
| Q36088110 | Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. |
| Q54473799 | Subclinical atherosclerosis in ankylosing spondylitis: is there a role for inflammation? |
| Q37689488 | Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins |
| Q50192090 | The Role of Statins in Disease Modification and Cardiovascular Risk in Rheumatoid Arthritis. |
| Q34398263 | The comparative effectiveness of statin therapy in selected chronic diseases compared with the remaining population. |
Search more.